• 1
    Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993; 138: 15966.
  • 2
    Schjoldager BT, Mortensen PE, Christiansen J, Orskov C, Holst JJ. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 1989; 34: 7038.
  • 3
    Schirra J, Kuwert P, Wank U et al. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 1997; 109: 8497.
  • 4
    Schirra J, Leicht P, Hildebrand P et al. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7–36)amide in non-insulin dependent diabetes mellitus. J Endocrinol 1998; 156: 17786.
  • 5
    Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998; 102: 76474.
  • 6
    Schirra J, Wank U, Arnold R, Goke B, Katschinski M. Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans. Gut 2002; 50: 3418.
  • 7
    Moens K, Heimberg H, Flamez D et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996; 45: 25761.
  • 8
    Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 1996; 271: E45864.
  • 9
    Schwartz TW. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 141125.
  • 10
    Azpiroz F, Malagelada JR. Importance of vagal input in maintaining gastric tone in the dog. J Physiol 1987; 384: 51124.
  • 11
    Lidums I, Hebbard GS, Holloway RH. Effect of atropine on proximal gastric motor and sensory function in normal subjects. Gut 2000; 47: 306.
  • 12
    Delgado-Aros S, Kim DY, Burton DD et al. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 2002; 282: G42431.
  • 13
    Kristensson K, Nordborg C, Olsson Y, Sourander P. Changes in the vagus nerve in diabetes mellitus. Acta Pathol Microbiol Scand A 1971; 79: 6845.
  • 14
    Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92: 3013.
  • 15
    Guo YP, McLeod JG, Baverstock J. Pathological changes in the vagus nerve in diabetes and chronic alcoholism. J Neurol Neurosurg Psychiatry 1987; 50: 144953.
  • 16
    Kanatsuka A, Osegawa M, An T, Suzuki T, Hashimoto N, Makino H. Augmented gastrin responses in diabetic patients with vagal neuropathy. Diabetologia 1984; 26: 44952.
  • 17
    Buysschaert M, Donckier J, Dive A, Ketelslegers JM, Lambert AE. Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes 1985; 34: 11815.
  • 18
    Nakamura T, Takebe K, Imamura K et al. Decreased gastric secretory functions in diabetic patients with autonomic neuropathy. Tohoku J Exp Med 1994; 173: 199208.
  • 19
    Kostic N, Novakovic R, Stajic S, Ratkovic M. Association of autonomic neuropathies and gastrointestinal peptides in non-insulin dependent diabetics. Med Pregl 1994; 47: 16871.
  • 20
    Powley TL. Vagal circuitry mediating cephalic-phase responses to food. Appetite 2000; 34: 1848.
  • 21
    Low PA, Opfer-Gehrking TL, Zimmerman IR, O'Brien PC. Evaluation of heart rate changes: electrocardiographic versus photoplethysmographic methods. Clin Auton Res 1997; 7: 658.
  • 22
    Low PA, Pfeifer MA. Standardization of autonomic function. In: Clinical Autonomic Disorders: Evaluation and Management, Low PA (ed.), Philadelphia: Lippincott-Raven, 1997: 28795.
  • 23
    Low PA, Opfer-Gehrking TL. The autonomic laboratory. Am J Electroneurodiagn Technol 1999; 39: 6576.
  • 24
    Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Effect of glucagon-like peptide 1(7–36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes 2000; 49: 61117.
  • 25
    Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78–107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993; 38: 66573.
  • 26
    Schirra J, Houck P, Wank U, Arnold R, Goke B, Katschinski M. Effects of glucagon-like peptide-1(7–36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans (see comments). Gut 2000; 46: 62231.
  • 27
    Kuiken SD, Samsom M, Camilleri M et al. Development of a test to measure gastric accommodation in humans. Am J Physiol 1999; 277: G1217G1221.
  • 28
    Kim D-Y, Delgado-Aros S, Camilleri M et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001; 96: 3099105.
    Direct Link:
  • 29
    Bouras EP, Delgado-Aros S, Camilleri M et al. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Gut 2002; 51: 7816.
  • 30
    Delgado-Aros S, Burton DD, Brinkmann BH, Camilleri M. Reliability of a semi-automated analysis to measure gastric accommodation using SPECT in humans. Gastroenterology 2001; 120: A287.
  • 31
    Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 134652.
  • 32
    Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 1997; 273: G920G927.
  • 33
    Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 1988; 271: 51932.
  • 34
    Salazar I, Vaillant C. Glucagon-like immunoreactivity in hypothalamic neurons of the rat. Cell Tissue Res 1990; 261: 3558.
  • 35
    Uttenthal LO, Toledano A, Blazquez E. Autoradiographic localization of receptors for glucagon-like peptide-1 (7–36) amide in rat brain. Neuropeptides 1992; 21: 1436.
  • 36
    Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 1995; 7: 2294300.
  • 37
    Greenberg GR, Chan B, Nordgren SR, Alleyne J. Effect of vagal blockade on food- and hormone-stimulated release of pancreatic polypeptide and motilin in dogs. Dig Dis Sci 1985; 30: 94653.
  • 38
    Fried GM, Ogden WD, Sakamoto T, Greeley GH Jr., Thompson JC. Experimental evidence for a vagally mediated and cholecystokinin-independent enteropancreatic reflex. Ann Surg 1985; 202: 6974.
  • 39
    Johnson CD, Chayvialle JA, Devaux MA, Sarles H. Neural pathways for the release of gastrin, cholecystokinin, and pancreatic polypeptide after a meal in dogs. Role of gastric and splanchnic nerves. Dig Dis Sci 1986; 31: 13619.
  • 40
    Niebel W, Eysselein VE, Singer MV. Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog. Dig Dis Sci 1987; 32: 10049.
  • 41
    Abrahamsson H. Studies on the inhibitory nervous control of gastric motility. Acta Physiol Scand Suppl 1973; 390: 138.
  • 42
    Andrews PL, Lawes IN. Characteristics of the vagally driven non-adrenergic, non-cholinergic inhibitory innervation of ferret gastric corpus. J Physiol 1985; 363: 120.
  • 43
    Azpiroz F, Malagelada JR. Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am J Physiol 1986; 251: G72735.
  • 44
    De Ponti F, Azpiroz F, Malagelada JR. Relaxatory responses of canine proximal stomach to esophageal and duodenal distension. Importance of vagal pathways. Dig Dis Sci 1989; 34: 87381.
  • 45
    Takasugi S, Ueda T, Kurata Y, Kodama M, Ezaki H, Fujii K. Neural and humoral factors influence gastric receptive relaxation in dogs. Jpn J Surg 1982; 12: 20813.
  • 46
    Kimura A, Sato A, Sato Y, Trzebski A. Role of the central and arterial chemoreceptors in the response of gastric tone and motility to hypoxia, hypercapnia and hypocapnia in rats. J Auton Nerv Syst 1993; 45: 7785.
  • 47
    Azpiroz F, Malagelada JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987; 92: 93443.
  • 48
    Takahashi T, Owyang C. Characterization of vagal pathways mediating gastric accommodation reflex in rats. J Physiol 1997; 504: 47988.
  • 49
    Stadaas JO. Gastric motility 1 year after proximal gastric vagotomy. Scand J Gastroenterol 1980; 15: 799804.
  • 50
    Hartley MN, Mackie CR. Gastric adaptive relaxation and symptoms after vagotomy. Br J Surg 1991; 78: 247.
  • 51
    Grundy D, Gharib-Naseri MK, Hutson D. Plasticity in the gastric inhibitory innervation after immunization against VIP and vagotomy in the ferret. Am J Physiol 1993; 265: G4329.
  • 52
    Samsom M, Roelofs JM, Akkermans LM, Berge Henegouwen GP, Smout AJ. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998; 43: 4916.
  • 53
    Undeland KA, Hausken T, Aanderud S, Berstad A. Lower postprandial gastric volume response in diabetic patients with vagal neuropathy. Neurogastroenterol Motil 1997; 9: 1924.
  • 54
    Samsom M, Salet GA, Roelofs JM, Akkermans LM, Vanberge-Henegouwen GP, Smout AJ. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 1995; 40: 203742.
  • 55
    Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol 2000; 95: 117583.
    Direct Link:
  • 56
    Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995; 109: 75565.